Suresh B. Singh

3.7k citations

47 papers · 2.8k indexed · 1 hit paper · h-index 25

Molecular Biology top 5%
Organic Chemistry top 1%
Computational Theory and Mathematics top 1%
Oncology top 10%
Pharmacology top 5%

Co-authors: Ya‐Jun Zheng Colin M. Tice Robert P. Sheridan Mu Gao Jeffrey Skolnick Eugene M. Fluder Hongyi Zhou Peter A. Kollman
Topics: Computational Drug Discovery Methods (15 papers)DNA and Nucleic Acid Chemistry (8 papers)Synthesis and biological activity (7 papers)
Cited by: Organic Chemistry Computational Theory and Mathematics Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: United States Brazil Israel

In The Last Decade

Suresh B. Singh

47 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The use of spirocyclic scaffolds in drug discovery

2014 857 citations Ya‐Jun Zheng, Colin M. Tice et al. Bioorganic & Medicinal Chemistry Letters profile →

Peers

Countries citing papers authored by Suresh B. Singh

Since Specialization

Citations

This map shows the geographic impact of Suresh B. Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh B. Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh B. Singh more than expected).

Fields of papers citing papers by Suresh B. Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh B. Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh B. Singh. The network helps show where Suresh B. Singh may publish in the future.

Co-authorship network of co-authors of Suresh B. Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh B. Singh. A scholar is included among the top collaborators of Suresh B. Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh B. Singh. Suresh B. Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Conformational control in structure-based drug design 2017 ·Bioorganic & Medicinal Chemistry Letters ·Ya‐Jun Zheng,Colin M. Tice,Suresh B. Singh	40
2	An electronic environment and contact direction sensitive scoring function for predicting affinities of protein–ligand complexes in Contour® 2014 ·Journal of Molecular Graphics and Modelling ·Peter Lindblom,Guosheng Wu,(unknown),(unknown),John J. Baldwin,Richard E. Gregg,David A. Claremon,Suresh B. Singh	4
3	The use of spirocyclic scaffolds in drug discoverybreakdown → 2014 ·Bioorganic & Medicinal Chemistry Letters ·Ya‐Jun Zheng,Colin M. Tice,Suresh B. Singh	857
4	Structure Based Design of 11β-HSD1 Inhibitors 2010 ·Current Pharmaceutical Biotechnology ·Suresh B. Singh,Colin M. Tice	9
5	Discovery of new binding elements in DPP-4 inhibition and their applications in novel DPP-4 inhibitor design 2008 ·Bioorganic & Medicinal Chemistry Letters ·Gui‐Bai Liang,Xiaoxia Qian,Tesfaye Biftu,Suresh B. Singh,Ying‐Duo Gao,Giovanna Scapin,Sangita B. Patel,Barbara Leiting,Reshma A. Patel,Joseph K. Wu,Xiaoping Zhang,Nancy A. Thornberry,Ann E. Weber	20
6	Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin 2007 ·Bioorganic & Medicinal Chemistry Letters ·Tesfaye Biftu,Giovanna Scapin,Suresh B. Singh,Dennis Feng,(unknown),George J. Eiermann,Huaibing He,Kathy Lyons,Sangita B. Patel,Aleksandr Petrov,Ranabir SinhaRoy,Bei Zhang,Joseph K. Wu,Xiaoping Zhang,George A. Doss,Nancy A. Thornberry,Ann E. Weber	51
7	Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Meng‐Hsin Chen,(unknown),Suresh B. Singh,Edward A. O’Neill,Cheryl D. Schwartz,Chris M. Thompson,Stephen J. O’Keefe,Dennis M. Zaller,James B. Doherty	38
8	(3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes 2006 ·Bioorganic & Medicinal Chemistry Letters ·Tesfaye Biftu,Dennis Feng,Xiaoxia Qian,Gui‐Bai Liang,G. R. KIECZYKOWSKI,George J. Eiermann,Huaibing He,Barbara Leiting,Kathy Lyons,Aleksandr Petrov,Ranabir SinhaRoy,Bei Zhang,Giovanna Scapin,(unknown),Ying‐Duo Gao,Suresh B. Singh,Joseph K. Wu,Xiaoping Zhang,Nancy A. Thornberry,Ann E. Weber	34
9	p38 MAP kinase inhibitors. Part 6: 2-Arylpyridazin-3-ones as templates for inhibitor design 2006 ·Bioorganic & Medicinal Chemistry Letters ·S. Natarajan,Stephen T. Heller,Kiyean Nam,Suresh B. Singh,Giovanna Scapin,Sangita B. Patel,James E. Thompson,Catherine E. Fitzgerald,Stephen J. O’Keefe	19
10	Selective Inhibition of Dog Hepatic CYP2B11 and CYP3A12 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Ping Lü,Suresh B. Singh,Brian Carr,Yulin Fang,Cathie Xiang,Thomas H. Rushmore,A. David Rodrigues,Magang Shou	29
11	Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Luping Liu,Sangita B. Patel,James V. Pivnichny,Giovanna Scapin,Suresh B. Singh,Cornelis E. C. A. Hop,Zhen Wang,John R. Strauss,Patricia M. Cameron,E.A. Nichols,Stephen J. O’Keefe,Edward A. O’Neill,Dennis M. Schmatz,Cheryl D. Schwartz,Chris M. Thompson,Dennis M. Zaller,James B. Doherty	66
12	SAR of 3,4-Dihydropyrido[3,2-d]pyrimidone p38 inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Luping Liu,(unknown),S. Natarajan,Meng‐Hsin Chen,Suresh B. Singh,Cheryl D. Schwartz,Catherine E. Fitzgerald,Stephen J. O’Keefe,Dennis M. Zaller,Dennis M. Schmatz,James B. Doherty	102
13	The role of tryptophan 1072 in human PDE3B inhibitor binding 2003 ·Biochemical and Biophysical Research Communications ·Caroline Chung,Jeffrey P. Varnerin,Nancy R. Morin,Douglas J. MacNeil,Suresh B. Singh,Sangita B. Patel,Giovanna Scapin,Lex H.T. Van der Ploeg,Michael R. Tota	7
14	p38MAP kinase inhibitors. part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold 2003 ·Bioorganic & Medicinal Chemistry Letters ·S. Natarajan,David D. Wisnoski,Suresh B. Singh,(unknown),Edward A. O’Neill,Cheryl D. Schwartz,Chris M. Thompson,Catherine E. Fitzgerald,Stephen J. O’Keefe,Sanjeev Kumar,Cornelis E. C. A. Hop,Dennis M. Zaller,Dennis M. Schmatz,James B. Doherty	32
15	A simple method for visualizing the differences between related receptor sites 2002 ·Journal of Molecular Graphics and Modelling ·Robert P. Sheridan,M. Katharine Holloway,Georgia B. McGaughey,Ralph T. Mosley,Suresh B. Singh	14
16	Hematopoietic Progenitor Kinase 1 Associates Physically and Functionally with the Adaptor Proteins B Cell Linker Protein and SLP-76 in Lymphocytes 2001 ·Journal of Biological Chemistry ·Karsten Sauer,Jen Liou,Suresh B. Singh,Deborah Yablonski,Arthur Weiss,Roger M. Perlmutter	98
17	Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β3 adrenergic receptor agonists 2000 ·Bioorganic & Medicinal Chemistry Letters ·Emma R. Parmee,Linda Brockunier,Jiafang He,Suresh B. Singh,Mari R. Candelore,Margaret A. Cascieri,Liping Deng,Yong Liu,Laurie Tota,Matthew J. Wyvratt,Michael H. Fisher,Ann E. Weber	12
18	Understanding the thermodynamic stability of an RNA hairpin and its mutant 1996 ·Biophysical Journal ·Suresh B. Singh,Peter A. Kollman	14
19	Molecular Dynamics Simulation of a Tumorigenic Benzo[a]pyrene Metabolite Bound to DNA at a Single Strand‐Double Strand Junction^a 1994 ·Annals of the New York Academy of Sciences ·Suresh B. Singh,Bin Li,Brian E. Hingerty,Robert Shapiro,Suse Broyde	4
20	Free energy component analysis: application to the “Z-Phobicity” of A · T base pairs 1993 ·Journal of Biomolecular Structure and Dynamics ·Suresh B. Singh,David A. Pearlman,Peter A. Kollman	4

About Suresh B. Singh

Suresh B. Singh is a scholar working on Computational Theory and Mathematics, Organic Chemistry and Pharmacology, having authored 47 papers that have together received 2.8k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (15 papers), DNA and Nucleic Acid Chemistry (8 papers) and Synthesis and biological activity (7 papers). The work is most often cited by research in Organic Chemistry (1.2k citations), Computational Theory and Mathematics (429 citations) and Molecular Biology (1.3k citations). Suresh B. Singh has collaborated with scholars based in United States, Brazil and Israel. Frequent co-authors include Ya‐Jun Zheng, Colin M. Tice, Robert P. Sheridan, Mu Gao, Jeffrey Skolnick, Eugene M. Fluder, Hongyi Zhou, Peter A. Kollman, Simon K. Kearsley and Suse Broyde. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact